3D Global Biotech (ROCO:6808) Total Assets: NT$1,090.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6808 3D Global Biotech Inc ROCO:6808
70 GF Score
Price NT$38.85
GF Value NT$186.06
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is 3D Global Biotech Total Assets?

3D Global Biotech ROCO:6808 -3.00% 70 Total Assets is NT$1,090.6 Mil as of Dec. 2025. GuruFocus rates ROCO:6808 with a GF Score™ of 70/100 and a GF Value™ of NT$186.06 (Significantly Undervalued). The stock has 5 warning signs investors should review.

3D Global Biotech's Total Assets for the quarter that ended in Dec. 2025 was NT$1,090.6 Mil.

During the past 12 months, 3D Global Biotech's average Total Assets Growth Rate was 83.80% per year. During the past 3 years, the average Total Assets Growth Rate was 55.60% per year. During the past 5 years, the average Total Assets Growth Rate was 22.50% per year.

During the past 9 years, 3D Global Biotech's highest 3-Year average Total Assets Growth Rate was 55.60%. The lowest was -8.40%. And the median was -3.55%.

Total Assets is connected with ROA %. 3D Global Biotech's annualized ROA % for the quarter that ended in Dec. 2025 was 4.85%. Total Assets is also linked to Revenue through Asset Turnover. 3D Global Biotech's Asset Turnover for the quarter that ended in Dec. 2025 was 0.10.

3D Global Biotech  (ROCO:6808) Total Assets Explanation

Total Assets is connected with ROA %.

3D Global Biotech's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=52.13/( (1058.13+1090.647)/ 2 )
=52.13/1074.3885
=4.85 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

3D Global Biotech's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=103.891/( (1058.13+1090.647)/ 2 )
=103.891/1074.3885
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

3D Global Biotech Total Assets Related Terms

3D Global Biotech Total Assets Historical Data

* Premium members only.

The historical data trend for 3D Global Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Global Biotech Total Assets Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only 424.52 371.26 324.15 1,037.57 1,090.65

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 324.15 515.61 1,037.57 1,058.13 1,090.65
ROCO:6808
70GF Score
3D Global Biotech Inc ROCO:6808
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3D Global Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

3D Global Biotech's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=984.528+106.119
=1,090.6

3D Global Biotech's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=984.528+106.119
=1,090.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$1,090.6 Mil mean?
3D Global Biotech (ROCO:6808) has a Total Assets of NT$1,090.6 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on 3D Global Biotech and its competitors.
Is 3D Global Biotech's Total Assets too high?
3D Global Biotech's current Total Assets is NT$1,090.6 Mil. Overall, 3D Global Biotech has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 3D Global Biotech's Total Assets compare to VRTX and REGN?
3D Global Biotech's Total Assets of NT$1,090.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on 3D Global Biotech and its competitors. 3D Global Biotech's current Total Assets is NT$1,090.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3D Global Biotech stock overvalued right now?
Based on GuruFocus' analysis, 3D Global Biotech (ROCO:6808) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$186.06, compared to a current price of NT$38.85 — trading 79.1% below its estimated fair value. The current Total Assets is NT$1,090.6 Mil. 3D Global Biotech's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For 3D Global Biotech (ROCO:6808), the current Total Assets is NT$1,090.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3D Global Biotech (ROCO:6808) Overvalued in 2026?

Based on GuruFocus' analysis, 3D Global Biotech stock appears to be undervalued. The current stock price of NT$38.85 is trading 79.1% below its estimated GF Value™ of NT$186.06. GuruFocus considers 3D Global Biotech to be Significantly Undervalued.

Key valuation signals for ROCO:6808:

  • Total Assets: NT$1,090.6 Mil
  • GF Value™: NT$186.06 vs. price of NT$38.85 (79.1% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6808 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3D Global Biotech Business Description

Address No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
70GF Score

Get the complete analysis for ROCO:6808

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.85
Price
NT$186.06
GF Value